Medicine guide
SUNLENCA 464 mg
As listed in the register: SUNLENCA 464 mg, solution injectable
· solution injectable
- Prescription only
- Active substance
- Lénacapavir Sodique
- Made by
- GILEAD SCIENCES IRELAND UC (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | GILEAD SCIENCES IRELAND UC (IRLANDE) |
|---|---|
| Active substance | Lénacapavir Sodique |
| Form | solution injectable |
| Route | sous-cutanée |
| Dispensing (as stated by the register) | prescription initiale hospitalière annuelle · liste I · renouvellement non restreint |
| Marketed | Yes, according to the register |
| Reinforced monitoring | Yes — under reinforced monitoring, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/22/1671 |
| Name in the register | SUNLENCA 464 mg, solution injectable |
| Packs | 2 flacon(s) en verre de 1,5 ml + 2 adaptateur(s) pour flacon + 2 seringue(s) + 2 aiguille(s) |
| CIS | 65950064 |
| CIP13 | 3400930258064 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.